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ABSTRACT
Background. Branched-chain amino acids (BCAA) i.e., leucine (Leu), isoleucine
(Ile) and valine (Val) are important amino acids, which metabolism play a role in
maintaining system energy homeostasis at rest and during exercise. As recently shown
lowering of circulating BCAA level improves insulin sensitivity and cardiac metabolic
health. However, little is known concerning the impact of a single bout of incremental
exercise and physical training on the changes in blood BCAA. The present study aimed
to determine the impact of a gradually increasing exercise intensity—up to maximal
oxygen uptake (VO2max) on the changes of the plasma BCAA [
∑
BCAA]pl, before and
after 5-weeks of moderate-intensity endurance training (ET).
Methods. Ten healthy young, untrainedmenperformed an incremental cycling exercise
test up to exhaustion to reach VO2max, before and after ET.
Results. We have found that exercise of low-to-moderate intensity (up to ∼50%
of VO2max lasting about 12 min) had no significant effect on the [
∑
BCAA]pl,
however the exercise of higher intensity (above 70% of VO2max lasting about 10 min)
resulted in a pronounced decrease (p< 0.05) in [
∑
BCAA]pl. The lowering of plasma
BCAA when performing exercise of higher intensity was preceded by a significant
increase in plasma lactate concentration, showing that a significant attenuation of
BCAA during incremental exercise coincides with exercise-induced acceleration of
glycogen utilization. In addition, endurance training, which significantly increased
power generating capabilities at VO2max (p= 0.004) had no significant impact on the
changes of [
∑
BCAA]pl during this incremental exercise.
Conclusion. We have concluded that an exercise of moderate intensity of relatively
short duration generally has no effect on the [
∑
BCAA]pl in young, healthy men,
whereas significant decrease in [
∑
BCAA]pl occurs when performing exercise in heavy-
intensity domain. The impact of exercise intensity on the plasma BCAA concentration
seems to be especially important for patients with cardiometabolic risk undertaken
cardiac rehabilitation or recreational activity.
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INTRODUCTION
Amino acids in human body are present mainly in the form of proteins, most of which
are contained in skeletal muscles (40–45% of total body protein pool), whereas the pool of
free amino acids constitutes less than 2% of total body amino acids. Among the essential
amino acids (which cannot be synthesized from other metabolites in human body), the
branched-chain amino acids (BCAA) i.e., leucine (Leu), isoleucine (Ile) and valine (Val),
are the most relevant amino acids metabolized during exercise (Wagenmakers et al., 1989).
Interestingly, circulating BCAA constitute also a biomarker of cardiometabolic diseases
(Batch et al., 2013; White & Newgard, 2019). As suggested recently, BCAA by promoting
lipid storage in liver and in skeletal muscles contribute to insulin resistance (White
& Newgard, 2019). The genetic association studies by Lotta et al. (2016) shown strong
relationship between higher circulating level of BCAA and type 2 diabetes in humans.
In addition, Wang et al. (2011) found that five circulating branched-chain and aromatic
amino acids (including leucine, isoleucine, valine, tyrosine and phenylalanine) might be
used as early markers of diabetes risk. On the other hand, restriction of dietary BCAA
by lowering of circulating BCAA levels improves whole-body and skeletal muscle insulin
sensitivity in obese rats (White et al., 2016) and lowers lipid accumulation in their hearts,
which has positive impact on cardiometabolic health (McGarrah et al., 2020).
It is well known that regular exercise exerts beneficial effects on the human general health
including an improvement of insulin sensitivity (Holloszy, 2005). Since skeletal muscle
accounts for about 60–80% of postprandial insulin-mediated glucose uptake (Meyer et al.,
2002; Soulage et al., 2018), muscle insulin resistance play a key role in the disturbances in
glucose homeostasis. Considering the role of BCAA in the insulin resistance and taking
into account that skeletal muscles is a major tissue that utilizes BCAA, BCAA oxidation
during exercise might have an important impact on the maintaining glucose homeostasis.
Specifically, a lowering of circulating BCAA concentration during exercise, which reflects an
increase of the BCAA uptake and an enhancement of BCAA catabolism by skeletal muscles
during exercise, decreases the risk of an accumulation of BCAA catabolic intermediates,
which are known to be involved in the lipid accumulation contributing to muscle insulin
resistance (White & Newgard, 2019). Aswas recently found, 3-Hydroxyisobutyrate (3-HIB),
a catabolic intermediate of valine, is indeed positively correlated with insulin resistance in
humans (Nilsen et al., 2020).
During exercise BCAA release from splanchnic bed increases and is accompanied
by an elevated BCAA uptake by contracting muscles and by an enhancement of BCAA
oxidation therein (Wagenmakers et al., 1989). The mechanism responsible for BCAA
oxidation in skeletal muscles is attributed to activation of the branched-chain α-keto acid
dehydrogenase (BCKDH) complex – rate limiting enzyme of branched-chain oxoacid
oxidation (Wagenmakers et al., 1989; Van Hall et al., 1996). It is generally believed that
BCAA are used as an energy substrate mainly during prolonged exercise (Blomstrand,
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Celsing & Newsholme, 1988) and might provide about 3–6% of the total energy demand
(Gibala, 2007). A significant decrease in plasma BCAA concentration in bloodstream has
been observed after sustained exercise (lasting about 1.5 h) as well as after marathon run
(Blomstrand, Celsing & Newsholme, 1988). It has been found that prolonged exercise (90
and 120 min duration) at 50–70% maximal power output increases the percentage of
active BCKDH in human skeletal muscle by 2- to 5-fold (Wagenmakers et al., 1989), which
suggests greater BCAA usage during prolonged exercise.
However, to our best knowledge no data has been presented so far showing the changes
of plasma BCAA concentration in varied exercise intensity domains (moderate vs heavy
exercise intensity) during incremental exercise. Incremental exercise tests are commonly
applied exercise protocols allowing to study physiological responses to varied exercise
intensities and to determine key features of exercise tolerance such as lactate threshold
(LT), maximal oxygen uptake (VO2max), power output at maximal oxygen uptake (POmax)
(Majerczak et al., 2014; Zoladz, Rademaker & Sargeant, 1995).
Therefore, in the present study we determined the changes in plasma BCAA
concentration during the moderate (up to 50% of VO2max) and heavy-intensity (above
70% of VO2max) exercise domains. We hypothesized that a strenuous exercise even of short
duration is accompanied by a significantly greater decrease in plasma BCAA concentration
than low-to-moderate intensity exercise. Moreover, we aim to establish the effect of
5-week moderate-intensity endurance training (often used in rehabilitation or as a part of
therapy in patients) on the plasma BCAA concentration in relation to exercise tolerance,
since the impact of endurance training on the BCAA concentration reported in previous
studies is not clear (Lamont, McCullough & Kalhan, 1999; McKenzie et al., 2000). Gaining
the missing knowledge on the impact of physical exercise of varied intensities and training
on the circulating BCAA in humans seems to be especially important in view of the studies




The study was approved by Local Ethical Committee in Krakow (No. 9 KBL/OIL/2009)
and performed according to guidelines of the Declaration of Helsinki. All volunteers
provided written consent for participation in the study after becoming acquainted with the
procedures and purpose of the study.
Subjects and study design
The studied group consisted of 10 healthy, non-smoking, untrained but recreationally
active, young men (mean ± SEM: age 22.3 ± 0.4 years; body mass (BM) 79.9 ± 2.7 kg;
height 181.0 ± 2.0 cm; body mass index (BMI) 24.3 ± 0.6 kg m−2; VO2max 45.6 ± 1.2
mL kg−1 min−1), who submitted written consent to participate in the study. Before the
experiment, participants were asked to follow a normal mixed diet during three days
prior to the exercise test that was composed of ∼55% of carbohydrates, ∼25% of fat and
∼20% of protein, and to avoid caffeinated and alcoholic beverages 48 h before exercise.
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All participants were informed that lifestyle changes may potentially affect the outcome of
this study, therefore, they were instructed to maintain their routine diet and asked not to
take any dietary supplements throughout the experiment.
The study started with a medical health examination and basic anthropometric
measurements. Blood analysis was performed in each subject including morphological
and biochemical parameters (see below). Then, subjects performed incremental exercise
up to exhaustion to determine exercise tolerance parameters including lactate threshold,
VO2max and POmax. During the incremental exercise blood samples were taken to analyze
plasma lactate and BCAA concentration. Based on this exercise test, the training intensities
were established individually for each subject and the 5-week endurance training of
moderate-intensity has started. After the training program, anthropometric measurements,
incremental exercise test and blood analyses were repeated (see below).
Exercise protocol
Subjects performed an incremental exercise on the cycloergometer Jaeger Ergo-Line
GmbH and Co KG800s (Bitz, Germany) at pedaling rates of 60 rev min−1. The subjects
were familiarized with the laboratory conditions and the exercise test about 3 days before
the onset of this study. The exercise test was preceded by a 6-minute resting period, after
which the power output (PO) was increased by 30 W every 3 min until exhaustion. During
exercise test gas exchange parameters were recorded continuously breath-by-breath using
the Oxycon Champion, Mijnhardt BV (Bunnik, The Netherlands) starting from the 6 min
before the test, up to 6 min after its ending (Majerczak et al., 2010; Zoladz, Rademaker
& Sargeant, 1995; Zoladz et al., 1998). The incremental exercise test was performed to
determine e.g., VO2max, POmax and LT. The following criteria of reaching VO2max during
incremental test have been applied: (1) at the end of the test a plateauing in VO2 in relation
to the increase in the power output was evident, (2) at the end of exercise the heart rate
(HR) was close to the age-predicted maximum (i.e., above 95% of predicted HRmax), (3)
the end-exercise plasma lactate concentration ([La−]pl) reached value above eight mmol
L−1 and the end-exercise respiratory quotient was above 1.10. The incremental test was
performed two days before and two days after five weeks of endurance training.
Endurance training protocol
Endurance training program was performed on cycloergometers Monark 874 E (Monark
Exercise AB, Vansbro, Sweden), four times per week throughout 5 weeks, at the pedaling
rates 60 rev min −1. All participants were subjected to two different kinds of training
exercise protocols. The first training exercise protocol consisted of continuous endurance
cycling at the power output corresponding to 90% of the VO2 found at the previously
determined lactate threshold. The second (intermittent endurance cycling) consisted of
6 min of unloaded cycling followed by a 3 min exercise bout performed at the power
output corresponding to 50% 1 (50% difference between the power output reached at
VO2max (POmax) and the power output obtained at the LT (PO at LT)), repeated 4 times
and finished with 4 min of unloaded cycling. Duration of each training bout equalled
40 min and the scaling of the training intensity was based on the principle that the main
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training workload should be performed in themoderate-intensity domain i.e., below the LT
(Whipp, 1996). In this study over 80% of the training workloads were of moderate intensity
i.e., they were performed with an intensity corresponding to about 68% of maximum heart
rate (HRmax) (about 50% of VO2max), whereas some of the training workloads (∼15%)
were planned to be performed in the heavy-intensity domain i.e., above the LT (Whipp,
1996). The continuous endurance cycling was performed on Tuesdays and Thursdays, and
the intermittent endurance cycling on Mondays and Fridays. Each training session was
monitored using a heart rate monitor (Polar S810, Finland) and supervised by at least one
member of the research team. During the 5 weeks training period, volunteers performed
on average 19.8± 0.2 training sessions (9.9± 0.1 sessions of continuous endurance cycling
in the moderate-intensity domain and 9.9± 0.1 sessions of intermittent endurance cycling
in the heavy-intensity domain), and the total training time amounted to 13.2 ± 0.1 h.
Compliance with the training program was excellent and amounted to 99 ± 1% (only one
subject missed two training sessions, because of short-term stomach problems). The details




Body mass was measured using standard anthropometric equipment (Radwag WPT 150,
Radom, Poland), with the participants lightly clothed and shoeless. Body fat percentage was
estimated using skinfold thickness measurements at the non-dominant upper arm triceps
and subscapular sites. The measurements were performed by the same investigator with a
calibrated skinfold caliper to the nearest 0.1 mm. The skinfold value was determined as the
logarithm value of the sum of the thickness in mm at the two sites and body fat content
was calculated using equation given by Hassager et al. (1986). Body fat percentage can be
calculated using this equation with a standard error of estimate (SEE) of 2.2 kg (2.8%).
Blood morphology and clinical chemistry parameters analysis
Blood samples for the assessment of basal hematological and biochemical variables were
taken in the fasting state from the antecubital vein. In addition, before, during and at the
end of incremental exercise blood samples were taken from the antecubital vein (in a fed
state, see below) via Abbot Int-Catheter, Ireland (18G/1.2× 45 mm) for plasma lactate and
plasma amino acids determination. Blood for complete blood count (CBC) was collected in
tubes containing EDTA, placed in a rocker for 30 min and stored in 4 ◦C, up to 24 h, until
analysis. Blood for parameters analyzed in plasma (pl), that is, glucose, insulin and BCAA,
was collected in plain tubes containing EDTA. Blood for plasma lactate [La−]pl analysis was
collected in tubes containing 1 mg ammonium oxalate and 5 mg sodium fluoride. Blood
samples after mixing were centrifuged at 653 g for 15 min at 4 ◦C. Blood for parameters
analyzed in serum (s), that is, sodium (Na+), potassium (K+), creatinine and urea, was
collected in plain tubes with a clotting activator and left to clot for a minimum of 30 min at
room temperature. Then, samples were centrifuged at 1,469 g for 10 min at 4 ◦C. Plasma
and serum were stored at −80 ◦C until analysis.
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Basal blood samples for measurements of blood variables: CBC (complete blood count),
Na+, K+, urea, glucose and insulin, were taken at rest in the fasting state between 7:30 and
8:00 a.m. The hematology (CBC) and biochemical (Na+, K+, urea, creatinine) tests were
performed as described previously (Grandys et al., 2009). Plasma glucose was measured
by enzymatic method (Vitros 950, Johnson and Johnson, USA) with the precision less
than 1.5%. Insulin was measured by IRMA using the INS-IRMA kit (BioSource, Belgium).
Analytical sensitivity for this measurement was 1 IU/ml and intra- and inter-assay CV were
< 2.4% and 6.8%. For IRMA method the radioactivity of the samples were measured by
using gamma scintillation counter (Wallac, Finland).
Blood samples (0.5 mL) for plasma lactate measurement [La−]pl were taken before
incremental exercise test (at rest, i.e., ∼2–3 h after light meal), at the end of each exercise
intensity during incremental exercise just before the next increment of power output and
at the end of the exercise protocol i.e., at exhaustion. [La−]pl was analyzed by enzymatic
method (Vitros 950, Johnson and Johnson, USA) as described previously (Majerczak et al.,
2010) with precision less than 1.4%.
Plasma amino acids measurements
In the present study we aimed to determine the plasma amino acids concentrations
(including BCAA) before exercise and during incremental exercise at strictly defined
exercise intensities. The blood samples (1 mL) were taken at rest (pre-exercise) and at
the power outputs corresponding to moderate exercise intensity (below LT), amounting
in our study to 120 W (∼50% of VO2max), heavy exercise intensity (between LT and
POmax), amounting in our study to 180W (∼70% of VO2max), and at the maximal exercise
intensity during the incremental exercise (at 100% of VO2max), amounting in our study
to ∼264 vs 286 W, respectively before and after the training programme. In the light of
the study by Felig & Wahren (1971), Bergström, Fürst & Hultman (1985) and Eriksson et al.
(1985) a short-term exercise of low-to-moderate intensity should not lead to significant
changes in BCAA concentration, but exercise of heavy intensity may affect their plasma
concentrations. Total plasma α-amino acids concentration (including nonessential amino
acids: alanine, arginine, asparagine, aspartate, glutamine, glutamate, glycine, proline,
serine and tyrosine; essential amino acids: histidine, isoleucine, leucine, lysine, methionine,
phenylalanine, threonine and valine) were determined using by Pico-Tag method. The
Waters Chemistry Package for Free Amino Acid Analysis and the Ultrafiltration Sample
Prep Kit (Waters, Milford, MA, USA) were used to perform the Pico-Tag method. 200 µL
of plasma was mixed in a 1:1 ratio with the internal standard solution (methionine sulfone,
0.4mM in 0.1 M HCl) and filtrated using the Amicon MPS-1 ultrafiltration device. After
filtration samples were reconstructed with drying solution consisting of a 2:2:1 mixture of
methanol: 1 M sodium acetate: triethylamine (TEA), dried under vacuum and dissolved
in 20 µL of derivatization reagent (7:1:1:1 solution of methanol: triethylamine (TEA):
water: phenylisothiocyanate (PITC)). The derivatization process lasted for 20 min at room
temperature and produced the corresponding phenylthiocarbonyl (PITC) derivatives. After
derivatization samples were dried in vacuum and finally dissolved in 100 µL of Pico-Tag
diluent (Waters, Milford, MA, USA) and injected. The column heater temperature was 46
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◦C, run time: 87 min, detector settings: 254 nm, 0.05 AUFS. The intra-assay coefficients
of variation (CV) for leucine, isoleucine and valine was 0.42%, 0.79% and 1.19%, and the
inter-assay CV was 2.04%, 3.53% and 2.27%, respectively. The method for plasma amino
acids analysis performed in the present study was controlled by the European Research
Network on Hereditary Metabolism (ERDNIM, MCA Lab, Netherlands).
Data analysis
The plasma concentration of leucine ([Leu]pl), isoleucine ([Ile]pl), valine ([Val]pl) and the
sum of those branched-chain amino acids ([
∑
BCAA]pl) during incremental exercise test
were presented as absolute values measured at rest (pre-exercise), at 120 W (i.e., power
output corresponding to ∼50% of VO2max), 180 W (i.e., power output corresponding to
∼70% of VO2max) and at POmax (at 100% of VO2max) both before and after the training.
Moreover, the changes in [Leu]pl, [Ile]pl, [Val]pl and [
∑
BCAA]pl during incremental
exercise was presented in two exercise intensity domains: (a) when cycling in the moderate-
intensity domain (below LT) and (b) when cycling in the heavy-intensity domain (above
LT). The changes in BCAA concentration in the moderate-intensity domain was calculated
as a difference (1MI) between concentration measured at 120 W (i.e. at power output
corresponding to ∼50% of VO2max) and concentration measured at rest (pre-exercise).
The change in BCAA concentration in the heavy-intensity domain (1HI) was calculated
as a difference between concentration measured at POmax (∼100% of VO 2max) and value
measured at 180 W (i.e., at power output corresponding to ∼70% VO2max). In addition
exercise-induced changes in BCAA concentrations from rest to end of the incremental
exercise was presented as a 1MAX i.e., the difference between the concentration measured
at POmax minus concentration at rest. The changes (1) in plasma BCAA concentration
were presented both during incremental exercise performed before and after the training.
In the present study lactate threshold was defined as the highest power output (PO)
above which [La−]pl showed a sustained increase of lactate at least 0.5mmol L−1in response
to increasing PO by 30 W of every 3 min of incremental cycling (Zoladz, Rademaker &
Sargeant, 1995; Zoladz et al., 2014).
Exercise-induced plasma volume changes were calculated using formula developed by
Van Beaumont (1972). Delta plasma volume (1PV) means difference between plasma
volume before and after maximal incremental exercise. All values of plasma amino acids
concentrations measured at intensity corresponding to POmax were recalculated according
to changes of plasma volume during incremental exercises using formula developed by
Berthoin et al. (2002).
The homeostatic model assessment of insulin resistance (HOMA-IR) was computed
based on the fasting concentration of glucose and insulin using the following formula:
HOMA-IR = [INS (µU mL−1) × GLU (mmol L−1)]/22.5, proposed by Matthews et al.
(1985).
Statistical analysis
The results are presented as means and standard errors. The critical level of significance
was set at p< 0.05. Statistical significance of differences for paired samples was tested using
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Table 1 Body composition and exercise tolerance in the group of studied subjects before and after 5-
weeks of the endurance training.
Variables Before training After training p-value
BM, kg 79.9± 2.7 78.7± 2.8 0.046
BF, % 15.7± 1.1 15.3± 0.9 0.19
VO2max, mL min−1 3627± 106 3701± 110 0.19
POmax, W 264± 8 286± 6 0.004
PO at LT, W 132± 8 129± 9 1.00
Time to exhaustion, min 26.4± 0.8 28.6± 0.6 0.004
HRmax, bt min−1 190± 3 194± 2 0.02
Notes.
BM, body mass; BF%, body fat percentage; VO2max, maximal oxygen uptake; POmax, power output reached at VO2max; PO at
LT, power output reached at lactate threshold; HRmax, maximum heart rate.
Data are shown as mean± S.E.M. Two-sided, exact, non-asymptotic p-values are presented (Wilcoxon signed-rank test).
non-parametric Wilcoxon-signed-rank test and non-asymptotic, exact, two-sided p-values
are presented.
In order to analyze the impact of exercise intensity (0, 120 W, 180 W, POmax) and
training (before and after) on the [Leu]pl, [Ile]pl, [Val]pl, [
∑
BCAA]pl and [La]pl the data
were analyzed using repeated measures 2-way ANOVA and planned comparisons were
performed to identify significant differences between the groups. Moreover, repeated
measures 2-way ANOVA was performed also to analyze the changes in [Leu]pl, [Ile]pl,
[Val] pl, [
∑
BCAA]pl and [La]pl in the different intensity domains (1MI, 1HI, 1max). The
obtained p- values were corrected using the Holm-Bonferroni method. In order to quantify
the dependence of ([Leu]pl, [Ile]pl, [Val]pl and [
∑
BCAA]pl) on glucose homeostasis
Spearman’s rank correlation coefficient was used. Statistical analysis was performed using
statistical packet STATISTICA 10.0 (Stat Soft, Tulsa, OK., USA) and StatXact 9.0 (Cytel
Software Corporation, Cambridge, MA, USA).
RESULTS
Body composition and physical exercise capacity before and after the
endurance training
A significant decrease in BM amounting to about 1.5%, was observed after endurance
training (Table 1). No significant changes in absolute VO2max was found (p = 0.19),
however there was a tendency to higher relative VO2max after the training program (45.6
± 1.2 vs 47.3 ± 1.3 mL kg−1 min−1, respectively before and after training, ∼4% increase,
p = 0.064).
The 5-week endurance training resulted in a significant increase (∼8%) in power output
reached at VO2max, whichwas accompanied by the significant increase in time to exhaustion
(Table 1). No significant changes in power output reached at lactate threshold (PO at LT)
was observed (Table 1).
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Table 2 Hematological and clinical chemistry parameters in the studied group of subjects before and
after 5-weeks of endurance training.
Variable Before training After training p-value
RBC,×1012 L−1 5.07± 0.06 4.97± 0.08 0.29
WBC,×109 L−1 5.14± 0.33 5.76± 0.38 0.13
MCV, fL 87.5± 1.1 87.2± 1.2 0.26
Ht, % 43.9± 0.8 42.6± 0.9 0.14
Hb, g dL−1 15.4± 0.3 15.7± 0.6 0.94
[Na+]s, mmol L−1 141.2± 0.3 141.8± 0.5 0.23
[K+]s, mmol L−1 4.17± 0.09 4.17± 0.11 0.95
[Creatinine]s, mol L−1 92.8± 3.0 90.9± 2.2 0.56
[Urea]s, mmol L−1 5.27± 0.31 5.01± 0.35 0.51
[Glucose]pl, mmol L−1 5.28± 0.09 5.17± 0.07 0.26
[Insulin]pl, mIU L−1 10.9± 1.2 9.59± 1.24 0.70
HOMA-IR 1.43± 0.16 1.25± 0.16 0.70
[6α−AA]pl, µmol L−1 2973± 139 3,067± 150 0.77
[6BCAA]pl, µmol L−1 503± 24 561± 32 0.17
Notes.
RBC, red blood cells; WBC, white blood cells; MCV, mean corpuscular volume; Ht, hematocrit; Hb, hemoglobin; [Na+]s,
serum sodium concentration; [K+]s, serum potassium concentration; [Creatinine]s, serum creatinine concentration; [Urea]s,
serum urea concentration; [Glucose]pl, plasma glucose concentration; [Insulin]pl, plasma insulin concentration; HOMA-IR,
homeostatic model assessment-insulin resistance; [6α− AA]pl, total plasma α-amino acids concentration; [6BCAA]pl, total
plasma branched-chain amino acids (sum of leucine, isoleucine and valine concentration).
Data are shown as mean± S.E.M. Two-sided, exact, non- asymptotic p-values are presented (Wilcoxon signed-rank test).
Hematological and clinical chemistry parameters in the studied group
of subjects before and after the endurance training
Basic hematological and clinical chemistry parameters measured at rest in a fasted state
as well as plasma amino acids concentration i.e., total α-amino acids (including the sum
of BCAA) and separately the sum of BCAA measured at rest in a fed state, before and
after the training program are presented in Table 2. No significant difference (p > 0.05) in
hematological parameters, electrolytes, glucose concentration and HOMA-IR were noticed
after the training in the studied group, when compared to the before training values.
Moreover, no significant difference in the total plasma amino acids concentrations as well
as the sum of BCAA was observed after the training when compared to the values obtained
before training.
Plasma volume change during single bout of exercise before and
after the endurance training
The average exercise-induced decrease in plasma volume (1PV) during the maximal
incremental exercise test before training amounted to about 13% and did not differ
significantly (p = 0.43) from its value during exercise performed after the training (1PV
about 15%).
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The changes of plasma BCAA and lactate concentration during
incremental cycling exercise
The changes in plasma leucine ([Leu]pl), isoleucine ([Ile]pl) and valine ([Val]pl) during
incremental exercise performed before and after 5 weeks of the endurance training are
presented in Figs. 1A–1C.
During incremental exercise performed before the training plasma valine concentration
at 120 W (∼50% of VO2max) was not significantly different than at rest (p> 0.05, Fig. 1C).
Plasma isoleucine concentration at 120 W was significantly lower than at rest (p < 0.01,
Fig. 1B), whereas a tendency to lower [Leu]pl, was present at 120W, when compared to rest
value (p = 0.07, Fig. 1A). There was no significant difference (p > 0.05) in [Leu]pl,[Ile]pl
and[Val]pl at intensity corresponding to 180 W (∼70% of VO2max) when compared to 120
W (∼50% of VO2max). However, at POmax(100% VO2max) plasma leucine, isoleucine and
valine was significantly lower when compared to their values at 180 W (∼70% of VO2max).
Moreover, plasma leucine, isoleucine and valine at POmaxwas significantly lower when
compared with their value at rest (p < 0.01, Figs. 1A–1C).
Since the changes of the [Leu]pl, [Ile]pl and [Val]pl during incremental exercise was
similar for those three amino acids (Figs. 1A–1C), we have also analyzed the changes of
the sum of BCAA ([
∑
BCAA]pl) during incremental exercise (Fig. 2A). We have found
that [
∑
BCAA]pl at 120 W was not significantly different than at rest, however a tendency
to mild decrease when cycling in this intesity domain was observed (p = 0.08, Fig. 2A).
No significant difference (p > 0.05) in [
∑
BCAA]pl at intensity corresponding to 180 W
(∼70% of VO2max) when compared to 120 W (∼50% of VO2max) was found, but at POmax
[
∑
BCAA]pl was significantly lower than at 180 W (∼70% of VO2max) (p< 0.01, Fig. 2A).
The changes in plasma lactate concentration ([La−] pl) during incremental exercise is
presented in Fig. 2B. An increase of power outputs from rest to 180 W was accompanied
initially by a mild (up to 120 W) and further by a steeper (between 120 and 180 W)
increase of plasma lactate concentration. However, exceeding 180 W (∼70% of VO2max)
was accompanied by very steep increase of [La−]pl which reached its maximum at POmax
(Fig. 2B).
The changes in [Leu]pl, [Ile]pl, [Val]pl and [
∑
BCAA]pl during incremental exercise
performed after the endurance training was similar to that reported before the training i.e.,
the effect of exercise intesity was always statistically significant (Figs. 1A–1C). In case of
lactate however, endurance training modified its concentration during exercise i.e., [La−]pl
after the traning was somewhat lower for intesities between 120 and 180 W, but visibly
higher for POmax, when compared to pre-training levels (significant interaction I*T, p =
0.004, Fig. 2B).
The changes in plasma BCAA and lactate concentration during cycling
performed in the moderate (1MI) versus heavy intensity (1HI) domain
When concerning the effect of exercise intensity on the BCAA changes during incremental
exercise a greater decrease in [Leu]pl,[Val]pl,[
∑
BCAA]pl (p< 0.05) and tendency to greater
decrease in [Ile]pl (p = 0.08) have been observed during cycling in the heavy-intensity
exercise domain i.e., above ∼70% of VO2max up to 100% VO2max (1HI) when compared
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Figure 1 The changes in plasma branched-chain amino acids concentrations during incremental cy-
cling exercise performed before and after the 5-weeks of the endurance training. The changes in plasma
leucine (A), plasma isoleucine (B), plasma valine (C) during incremental exercise performed before (black
bars) and after (white bars) the endurance training. The impact of factors: exercise intensity (I) and en-
durance training (T) on the analyzed variables is presented (repeated measures 2-way ANOVA, 2-sided p-
value). Asterisk (*) represents significantly lower concentrations from 180 W, 120 W and from rest (p <
0.01) and hash (#) denotes significantly lower concentrations than at rest (p < 0.01). Data are shown as
mean± S.E.M. Abbreviation: VO2max – maximal oxygen uptake; POmax – power output reached at 100%
of maximal oxygen uptake. The percentage of VO2max at the time zero represents the fraction of VO2max
measured in sitting position before exercise.
Full-size DOI: 10.7717/peerj.10491/fig-1
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Figure 2 The changes in the sum of plasma branched-chain amino acids concentrations and plasma
lactate concentration during incremental cycling exercise performed before and after the 5-weeks of
the endurance training. The changes in the sum of plasma BCAA concentration ([
∑
BCAA]pl, A) and
plasma lactate concentration ([La−]pl), B) during incremental exercise performed before (black bars) and
after (white bars) the endurance training. The impact of factors: exercise intensity (I) and endurance train-
ing (T) on the analyzed variables is presented (repeated measures 2-way ANOVA, 2-sided p-value). As-
terisk (*) represents significantly lower concentrations from 180 W, 120 W and from rest (p < 0.01) and
single cross (+) denotes significantly higher concentrations from the previous data point (p < 0.01). In
the case of ([La−]pl significant interaction between the two factors was observed (2-way ANOVA, I*T).
Data are shown as mean± S.E.M. Abbreviation: VO2max – maximal oxygen uptake; POmax – power out-
put reached at 100% of maximal oxygen uptake. The percentage of VO2max at the time zero represents the
fraction of VO2max measured in sitting position before exercise.
Full-size DOI: 10.7717/peerj.10491/fig-2
to cycling in the moderate-intensity exercise domain i.e., below ∼50% of VO2max (1MI)
(Fig. 3A).
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Figure 3 The impact of cycling performed before endurance training in the moderate (1MI) versus
heavy (1HI) intensity domain on the plasma branched-chain amino acids (A) and plasma lactate con-
centration (B). Asterisk (*) represents significant difference from1MI (p< 0.05, repeated measures 2-way
ANOVA). Data are shown as mean± S.E.M. Abbreviations: [Leu]pl, plasma leucine concentration; [Ile]pl,
plasma isoleucine concentration; [Val]pl, plasma valine concentration; [
∑
BCAA]pl, the sum of plasma
BCAA concentration, [La−]pl, plasma lactate concentration;1MI, the difference between value measured
at∼50% of VO2max and value measured at rest;1HI, the difference between value measured at 100% of
VO2max (POmax) and value measured at∼70% of VO2max.
Full-size DOI: 10.7717/peerj.10491/fig-3
When considering the changes in plasma lactate concentration significantly greater
increase in [La−]pl was found during cycling in the heavy-intensity domain when compared
to the moderate-intensity domain (p< 0.01 Fig. 3B).
The impact of 5-weeks of the endurance training on the plasma BCAA
concentration during incremental cycling exercise
No effect of 5-weeks of the endurance training (p > 0.05) on [Leu]pl,[Ile]pl,[Val]pl and∑
[BCAA]pl (Figs. 1A–1C and 2A) at rest and at appropriate exercise intensities (∼50%
of VO2max, ∼70% of VO2max, and at intensity corresponding to 100% VO2max) have
been observed. Moreover, no impact of endurance training on the changes (p > 0.05) in
[Leu]pl,[Ile]pl, [Val]pl and
∑
[BCAA]pl during cycling performed in moderate (Fig. 4A)
as well as in heavy (Fig. 4B) intensity domain were reported. Furthermore, no effect of
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Figure 4 The impact of 5-weeks of the endurance training on the plasma branched-chain amino acids
concentration during cycling in the varied intensity domains. The changes in plasma branched-chain
amino acids concentration during cycling performed in the moderate-intensity domain (from rest up to
50% of VO2max 1MI, A), heavy- intensity domain (above∼70% of VO2max,1HI, B) and during maximal
incremental cycling (from rest to 100% of VO2max -1max C) before (Pre) and after (Post) the training.
Data are shown as mean± S.E.M. Abbreviation: Abbreviations: [Leu]pl, plasma leucine concentration;
[Ile]pl, plasma isoleucine concentration; [Val]pl, plasma valine concentration; [
∑
BCAA]pl, the sum of
plasma BCAA concentration.
Full-size DOI: 10.7717/peerj.10491/fig-4
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Figure 5 The impact of 5-weeks of the endurance training on the plasma lactate concentration dur-
ing cycling in the varied intensity domains. The changes in plasma lactate concentration during cycling
performed in the moderate-intensity domain (up to∼50% of VO2max − 1MI, A), heavy- intensity do-
main (above 70% of VO2max -1HI, B) and during maximal incremental cycling (from rest to 100% of
VO2max -1max, C) before (Pre) and after (Post) the training. Data are shown as mean± S.E.M. Abbrevia-
tion: [La−]pl, plasma lactate concentration.
Full-size DOI: 10.7717/peerj.10491/fig-5
5 weeks of the endurance training (p > 0.05) on the maximal exercise-induced changes
(1max) in [Leu]pl[Ile]pl and
∑
[BCAA]pl, was observed, except a clear tendency to a greater
exercise-induced decrease in [Val]pl during maximal incremental cycling performed after
the training (p = 0.06, Fig. 4C).
The impact of 5-weeks of the endurance training on the plasma
lactate concentration during incremental cycling exercise
No effect of 5-weeks of endurance training (p > 0.05) on plasma lactate concentration at
rest and during exercise (i.e., at ∼50% of VO2max, ∼70% of VO2max and at 100% VO2max)
have been observed (Fig. 2B). A tendency to lower increase in [La−]pl, when cycling in the
moderate-intesity domain was found (p = 0.07, Fig. 5A) after 5 weeks of the endurance
training. On the other hand, a tendency to greater increase in [La−]pl,when cycling in the
heavy-intesity domain (p = 0.08, Fig. 5B) as well as during maximal incremental cycling
(p = 0.07, Fig. 5C) was reported after the training.
Correlation analysis
No significant correlation (p > 0.05) between resting leucine, isoleucine, valine
concentration and HOMA-IR both before and after the training was observed. A clear
tendency to positive correlation between training-induced changes in the sum of BCAA
[6 BCAA]pl at rest and training-induced change in basal glucose concentration was found
(r = 0.61, p = 0.06).
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DISCUSSION
The main finding of this study is that low-to-moderate intensity exercise (up to about
50% of VO2max) performed in young healthy men had essentially no significant impact
on the plasma branched-chain amino acids concentration in relation to their levels at
rest, however when cycling in heavy-intensity domain (i.e., above intensity corresponding
to 70% of VO2max) a significant decrease in plasma BCAA concentration have been
found. Interestingly, as presented in Fig. 2 the observed deeper decrease in plasma BCAA
concentration (above ∼70% of VO2max) was accompanied by the onset of a faster increase
in plasma lactate concentration. This suggests that the significant exercise-induced decrease
in BCAA is linked to the acceleration ofmuscle glycogenolysis during exercise.We have also
found that endurance training of moderate-intensity lasting 5 weeks resulting in significant
enhancement of exercise tolerance had no significant impact on the exercise-induced
changes in plasma BCAA concentrations.
The changes in BCAA concentration during single bout of
incremental exercise
In the present study we have analyzed the changes in plasma BCAA concentration during
incremental exercise until exhaustion lasting about 30 min, which is a typical exercise
test performed for the assessment of exercise tolerance (Majerczak et al., 2014; Zoladz,
Rademaker & Sargeant, 1995). We have found that a single bout of maximal incremental
exercise performed in young, untrained, but physically active men was accompanied
by a significant decrease (rest value versus intensity corresponding to VO2max) in leucine,
isoleucine, valine (Figs. 1A–1C) and in the sumof BCAA (Fig. 2A). The results of the present
study show that changes in BCAA concentration occur not only after prolonged, sustained
exercise, as demonstrated earlier (Blomstrand, Celsing & Newsholme, 1988; Wagenmakers
et al., 1989) but also are present after exercise of shorter duration (∼30 min). This might
be a consequence of a significant increase in BCKDH activity in skeletal muscle during
incremental exercise test as demonstrated by Howarth et al. (2007).
Similar effect i.e., a significant decrease in BCAA concentration (rest versus intensity
corresponding to VO2max) after single bout of whole body maximal graded exercise (an
increase in power output 50 W every 3 min) in the group of young, healthy subjects has
been observed in the study by Makhro et al. (2016). However, in the present study we
have additionally analyzed the changes in BCAA concentration in varied exercise intensity
domains during incremental exercise.We have found that short duration, low-to-moderate
intensity exercise (i.e., up to ∼50% of VO2max) seems to have no significant impact on
BCAA concentration (only a tendency to a mild decrease was observed below 50% of
VO2max and was followed by a plateau in BCAA in the range 50 and ∼70% of VO2max)
whereas even short duration but heavy-intensity exercise (>70% of VO2max) decreases
significantly circulating BCAA in young healthy men. Hence as consequence, we have
observed significantly greater decrease in plasma BCAA during heavy-intensity cycling in
comparison to cycling performed in the moderate-intensity domain (Fig. 3A). It should
be mentioned that the changes in plasma leucine, isoleucine and valine concentration
during single bout of incremental exercise found in the present study was similar for all
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three BCAA and also it was similar during exercise performed before and after the training
(Figs.1A–1C).
The exercise-induced significant decrease in plasma BCAA concentration, when
exceeding intensity corresponding to∼70% of VO2max might be a consequence of a greater
rate of BCAA uptake by working skeletal muscles than splanchnic release when cycling
in the heavy-intensity domain. Some authors postulated that higher exercise-induced
amino acid delivery to muscles, including BCAA, results from blood flow redistribution
during exercise with an involvement of epinephrine (Zoladz et al., 2015; Zouhal et al.,
2008). During heavy-intensity exercise skeletal muscles blood flow increases 100-fold when
compared to resting conditions (Zoladz et al., 2015) and at the same time blood flow to
liver is diminished by ∼50% when compared to its resting value (Bergeron et al., 2001).
The blood flow redistribution might indeed explain an increase in BCAA uptake by skeletal
muscles and a decrease in BCAA release from splanchnic bed (Brosnan, 2003; Zoladz et al.,
2015) leading to a decrease of BCAA in the bloodstream.
Another factor, which might contribute to a significant decrease in BCAA during heavy-
intensity exercise suggesting greater rate of their uptake by skeletal muscles could be related
to the effect of hormones – insulin and epinephrine. BCAA appear to be the most sensitive
amino acids to the insulin action, however based on the previous studies during incremental
exercise of similar pattern no changes in insulin concentration or even an attenuation of
plasma concentration of this hormone is observed (Galbo, 1983; Zoladz et al., 2002).
With regards to epinephrine, it has been demonstrated that epinephrine infusion exerts
hypoaminoacidemic effect i.e., decreases all amino acids concentrations including BCAA
and gluconeogenic amino acids in the bloodstream except alanine (Del Prato et al., 1990).
During incremental exercise plasma epinephrine concentration increases significantly when
exceeding the intensity corresponding to about 50% of VO2max (Galbo, 1983). Hence, an
increase in epinephrine during graded exercise from intensity corresponding to 50%
of VO2max (Galbo, 1983) might explain the significant decrease in BCAA concentration
observed in our study from intensity corresponding to ∼70% of VO 2max (Figs. 1A–1C
and Fig. 2A). Moreover, it is well known that an increase in epinephrine concentration
during incremental exercise (from∼50% of VO2max) precedes the acceleration of glycogen
utilization during exercise (Brooks & Mercier, 1994). It has been demonstrated that after
crossing the so called ‘crossover point’ (carbohydrates/fatty acids utilization point), which
in untrained subjects is localized at intensity corresponding to about ∼50% of VO2max,
glycogen utilization increases disproportionally faster, leading to its depletion (Brooks
& Mercier, 1994). As a consequence of an intensification of glycogenolysis in skeletal
muscles an increase in muscle and blood lactate accumulation occurs (Shulman, 2005).
Van Hall et al. (1996) found that the rate of BCAA utilization (as reflected by an increase
in percentage of active BCKDH complex) is higher (9-fold increase during exercise) in
glycogen-depleted leg when compared to the leg with normal glycogen level (4-fold). This
is consistent with the fact that BCAA can be used as an alternative source of energy for
glycogen depleted muscles. In the present study, we observed the significant decrease in
circulating BCAA concentration started at the exercise intensity corresponding to∼70% of
VO2max (Fig. 2A), which was preceded by an intensification of plasma lactate accumulation
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(Fig. 2B). This coincidence clearly suggests that in untrained subjects an increased glycogen
utilization in muscles during incremental exercise reflected by plasma lactate accumulation
(Fig. 2B) precedes greater BCAA usage (Fig. 2A) as energy substrate during cycling in the
heavy-intensity domain when compared to moderate exercise intensities.
Taking into account the role of systemic BCAA in the cardiometabolic risk, exercise
at higher intensity (>70% of VO2max) in healthy, young individuals seems to be more
effective in lowering of blood BCAA concentrations and in decreasing the cardiometabolic
risk.
The effect of 5-weeks of moderate-intensity endurance training on the
physical capacity and plasma BCAA concentration
The endurance training applied in the present study was composed mainly of moderate-
intensity exercise bouts (∼85% of training workloads was performed at intensity below
lactate threshold). Such training intensities i.e., low to moderate are often prescribed as
a part of therapy in cardiometabolic diseases which is a main cause of death in modern
societies (Holloszy, 2005; Nystoriak & Bhatnagar, 2018). Training program performed by
our subjects, amounting to a total of 20 exercise bouts, resulted in a significant increase in
physical capacity as reflected by an increase in power output reached at VO2max (by about
8%, p = 0.004) and by an increase in time to exhaustion (p = 0.004) after the training
program (Table 1). An enhancement of physical capacity as judged by an increase in exercise
duration and in enhancement of power generating capabilities after the applied training
program (Table 1) was not accompanied by a significant changes in BCAA during exercise
(Fig. 2A), except a clear tendency to greater decrease in plasma valine concentration during
maximal incremental cycling performed after the training (p = 0.06, Fig. 4C). Moreover,
we have observed no impact of endurance training on the circulating BCAA at rest and at
appropriate power outputs (Figs. 1A–1C, 2A and 4A–4C).
The applied training program of moderate intensity lasting 5 weeks in the studied group
of young healthy subjects did not change the insulin sensitivity as reflected by no changes
in HOMA-IR (p > 0.05, Table 2). However, we have observed a clear tendency to positive
correlation (p = 0.06) between training-induced change in the sum of BCAA at rest and
training-induced changes in glucose concentration. This results support the suggested
relation between higher plasma BCAA concentration with a decreased insulin sensitivity
(Lotta et al., 2016;Wang et al., 2011). On the other hand, no significant correlation between
training-induced changes in BCAA concentration at rest and changes in insulin resistance
reflected by HOMA-IR has been found.
Study limitations: It should be underlined that the present study involved male subjects
only in order to avoid a potential impact of sex differences. Therefore, the obtained results
can be considered as representative for young healthy male only and the conclusion of
the present study cannot be simply extrapolated to the females. Moreover, the number
of subjects participating in this study was relatively small (10 individuals), nevertheless,
this group was very homogeneous as described in the Method section. Furthermore, in
the present study we have shown the changes of BCAA concentration at rest and at three
exercise intensities—referring to moderate, heavy and severe intensity domain. It would
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be interesting to determine in the future the BCAA levels at all exercise stages during the
maximal incremental exercise test. Another limitation of this study is lack of a control
group. Taking into account the effect of circulating BCAA on insulin sensitivity and
cardiometabolic health one should also consider to determine the impact of exercise in
varied intensity domains on the BCAA concentrations in the group of participants at amore
advanced age (e.g., over 50 years old) and patients including patients with cardiovascular
disease and type 2 diabetes.
CONCLUSIONS
We have concluded, that an incremental exercise performed in young healthy men has
an impact on the plasma BCAA concentration in humans and in view of our results this
effect depends on the exercise intensity domain. Namely, a short duration bouts of exercise
(lasting about 12 min) of moderate intensity (up to about 50% of VO2max), as applied
in e.g., cardiac rehabilitation or in recreational activities, has essentially no significant
effect on the plasma BCAA concentrations in young healthy men. However, the exercise of
high-intensity—above 70% of VO2max (lasting only about 10min)—leads to a pronounced
decrease in plasma BCAA. This indicates that even short bouts of relatively high intensity
exercise can decrease plasma BCAA in young healthy people, which implies that regular
physical activity with implementation of heavy-intensity exercise bouts might be indeed
more effective when consider an improvement of insulin sensitivity and prevention of
type 2 diabetes. Concomitantly, endurance training of moderate-intensity lasting 5 weeks,
resulting in significant increase in exercise tolerance had no effect on the exercise-induced
changes in plasma BCAA concentrations. Taking into account the role of the BCAA in
cardiometabolic diseases the effect of physical activities on the plasma BCAA requires
further studies, especially in the group of patients with cardiometabolic risk.
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